Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bayesian designs with frequentist and Bayesian error rate considerations.

You-Gan Wang1, Denis Heng-Yan Leung, Ming Li

  • 1Department of Statistics and Applied Probability, National University of Singapore, Singapore. you-gan.wang@csiro.au

Statistical Methods in Medical Research
|October 27, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HIV estimation using population-based surveys with non-response: A partial identification approach.

Statistics in medicine·2024
Same author

Shrinkage empirical likelihood estimator in longitudinal analysis with time-dependent covariates--application to modeling the health of Filipino children.

Biometrics·2013
Same author

Lsr2 of Mycobacterium tuberculosis is a DNA-bridging protein.

Nucleic acids research·2008
Same author

Amphetamine selectively enhances avoidance responding to a less salient stimulus in rats.

Journal of neural transmission (Vienna, Austria : 1996)·2008
Same author

Retrospective analysis of anterior correction and fusion for adolescent idiopathic thoracolumbar/lumbar scoliosis: the relationship between preserving mobile segments and trunk balance.

International orthopaedics·2008
Same author

Intrarenal antigens activate CD4+ cells via co-stimulatory signals from dendritic cells.

Journal of the American Society of Nephrology : JASN·2008
Same journal

A joint model for a longitudinal outcome and a progressive multistate model under a mixed observation scheme.

Statistical methods in medical research·2026
Same journal

Efficient semi-supervised estimation of optimal individualized treatment regimes with survival outcome.

Statistical methods in medical research·2026
Same journal

Asymptotic online FWER control for dependent test statistics.

Statistical methods in medical research·2026
Same journal

Regression analysis of misclassified current status data with potentially unknown test accuracy.

Statistical methods in medical research·2026
Same journal

Bayesian multivariate linear mixed-effects models with varied association structures.

Statistical methods in medical research·2026
Same journal

Inference about the ratio of age-standardized rates between two overlapping populations.

Statistical methods in medical research·2026
See all related articles

This study introduces a Bayesian clinical trial design that controls frequentist error rates, offering an alternative to traditional frequentist methods for Phase II trials. The new design also manages Bayesian-type errors, enhancing trial reliability.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Medical Research Methodology

Background:

  • Traditional Phase II clinical trials predominantly use frequentist frameworks to control Type I and Type II errors.
  • Recent trends advocate for Bayesian designs, which typically stop trials based on posterior probabilities of treatment efficacy.
  • A gap exists in Bayesian designs that explicitly control frequentist error rates.

Purpose of the Study:

  • To propose a Bayesian clinical trial design that can control frequentist error rates.
  • To introduce a Bayesian adaptation of Simon's two-stage design for Phase II trials.
  • To evaluate the control of both frequentist and novel Bayesian-type errors.

Main Methods:

  • Development of a Bayesian version of Simon's two-stage design.

Related Experiment Videos

  • Incorporation of methods to control frequentist Type I and Type II errors within the Bayesian framework.
  • Definition and control of Bayesian-type errors analogous to posterior probabilities.

    • Main Results:

    • The proposed Bayesian design successfully controls frequentist error rates.
    • The method also demonstrates control over the newly defined Bayesian-type errors.
    • Numerical comparisons show the implications of different designs on error rates.

    Conclusions:

    • Bayesian clinical trial designs can be adapted to control frequentist error rates, bridging a gap between Bayesian and frequentist methodologies.
    • The novel Bayesian design offers a robust alternative for Phase II trials, managing both frequentist and Bayesian-type errors.
    • The study highlights the importance of considering various error metrics in clinical trial design, illustrated by a nasopharyngeal carcinoma trial example.